Diana Clare Hargreaves

Title: Diana Clare Hargreaves: Innovator in Cancer Treatment

Introduction

Diana Clare Hargreaves is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on improving the identification and treatment of cancer patients, particularly in relation to topoisomerase inhibitors.

Latest Patents

Hargreaves holds a patent for "Methods for identifying and treating cancer patients." This patent outlines methods for identifying cancer patients who are likely to respond to topoisomerase inhibitors or those who may fail to respond. The methods leverage the newly discovered role of BAF complexes in the decatenation of DNA by topoisomerase IIa. Cancer cells often exhibit defects in BAF complex activity, making them suitable targets for therapy using specific topoisomerase IIa inhibitors. The patent emphasizes that therapy using other topoisomerase inhibitors should be avoided for these cells.

Career Highlights

Diana Clare Hargreaves is affiliated with Leland Stanford Junior University, where she continues her research and development in cancer therapies. Her work has garnered attention for its potential to enhance treatment outcomes for cancer patients.

Collaborations

Hargreaves collaborates with notable colleagues, including Emily Carla Dykhuizen and Cigall Kadoch. These partnerships contribute to the advancement of her research and the implementation of her patented methods.

Conclusion

Diana Clare Hargreaves is a trailblazer in the field of cancer treatment, with her innovative methods poised to make a significant impact on patient care. Her dedication to research and collaboration underscores her commitment to improving cancer therapies.